Global Life Science Ventures — Investing in the life sciences

Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than € 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.

Home  Sitemap  Imprint

GLSV events

GLSV Annual Investors Meeting
June 3 - 4, 2008, Amsterdam, The Netherlands

Podiumsdiskussion (englisch): „Venture Capital: Finanzierungspartner für Biotech- und Medizintechnikfirmen
analytica, April 1 – 4, 2008, Messe München
Moderator: Andreas Uhde, Teilnehmer: Dr. Hubert Birner, Dr. Holger Reithinger, Dr. Alexander Asam, Joerg Ritter, ein Venture-Capital-finanziertes Biotechnologie Unternehmen
Click here for further information

7th Annual Biotech in Europe Investor Forum
October 2007 2nd -3rd, Zurich, Switzerland
Click here for further information

Phacilitate - Vaccine Forum
Amsterdam, 19-21 June 2006
Speaker Dr. Hans A. Küpper, Partner
Click here for further information

BioEquity Europe 2006
May 22nd-23rd 2006, Frankfurt, Germany
Click here for further information